GSK inks deal to promote shingles vaccine in China
9th Oct 2023 07:20
(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.
Read moreSunday newspaper round-up: Renewi, Metro Bank, New homes
8th Oct 2023 11:36
(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times
Read moreGSK raises £885.6m from Haleon share sale
6th Oct 2023 08:17
(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.
Read moreGSK's RSV vaccine gets approval in Japan
25th Sep 2023 07:28
(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.
Read moreUS FDA approves GSK treatment for myelofibrosis
18th Sep 2023 07:18
(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.
Read moreJapan considering GSK's Nucala drug for sinusitis treatment
1st Sep 2023 07:12
(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.
Read moreGSK reports positive results from shingles vaccine trials in China
23rd Aug 2023 07:04
(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.
Read moreSunday newspaper round-up: White Hydrogen, Bank of England, AI
13th Aug 2023 14:06
(Sharecast News) - America's Geological survey estimates that if even a small fraction of naturally occurring - and clean or so-called 'white' - hydrogen beneath the earth's surface were recovered, that would last for hundreds of years. Among the backers of the hydrogen industry is Bill Gates, who ploughed $90m into Koloma, a company hunting for natural hydrogen along the US's Midcontinental Rift System. White hydrogen has also been discovered in Europe, in France's Lorraine region. Nonetheless, the true potential of the stuff will hinge on the findings from those early projects, says Philip Ball, research fellow at Keele University. - Guardian
Read moreGSK lifts full-year guidance after 'excellent' Q2
26th Jul 2023 07:55
(Sharecast News) - GSK lifted its full-year guidance on Wednesday after an "excellent" second quarter.
Read moreGSK's ViiV gets Europe nod for HIV prophylaxis
24th Jul 2023 07:07
(Sharecast News) - Pharmaceuticals giant GSK announced on Monday that its majority-owned HIV specialist subsidiary ViiV Healthcare has received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), recommending marketing authorisation for 'cabotegravir' long-acting (LA) injectable and tablets for HIV prevention.
Read moreGSK gonorrhoea vaccine gets FDA fast track designation
27th Jun 2023 08:07
(Sharecast News) - GSK said on Tuesday that its investigational vaccine for sexually transmitted infection gonorrhoea has been granted a fast track designation by the US Food and Drug Administration.
Read moreGSK gets an approval in Japan, a recommendation in Europe
26th Jun 2023 07:43
(Sharecast News) - GSK announced two significant advancements on Monday, with the approval of an updated indication for Shingrix in Japan, as well as a positive opinion from the European Medicines Agency for daprodustat.
Read moreGSK reaches settlement in Goetz Zantac lawsuit
23rd Jun 2023 08:29
(Sharecast News) - GSK updated the market on the litigation regarding the now-discontinued heartburn drug ranitidine, or 'Zantac', on Friday.
Read moreEurope open: Stocks on the defensive after weak PMIs, euro awalloped
23rd Jun 2023 08:19
(Sharecast News) - Stocks on the Continent were trading on the back foot following the release of much weaker than expected readings for euro area factory and services activity.
Read moreUS CDC votes to recommend GSK's Arexvy against RSV
22nd Jun 2023 07:51
(Sharecast News) - America's public health watchdog endorsed GSK's Arexvy for use against Respiratory Syncytial Virus in adults over 60.
Read more